How many institutions held KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in Q3 2026?

6 institutional investors reported KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share for Q3 2026. Use the holders table for investor-level position and value details.

Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

Q: What does CUSIP 50127T109 represent in this 13F holders report?

CUSIP 50127T109 is the security identifier for KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 50127T109

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 26,005
Total 13F value: $274,494
Share change: +508
SEC-reported price per share: $10.71
Number of holders: 6
Value change: +$5,381
Number of buys: 3
Number of sells: 1
Shares outstanding: 88,406,412

Security key

50127T109

Report period

Q3 2026

Institutions

Top holders

KURA full security history Ownership snapshot Full 13F holder table Kura Oncology, Inc. SEC filings Kura Oncology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 50127T109

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOTECHNOLOGY VALUE FUND L P

Disclosed value leader

BlackRock, Inc.

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 13F Lead comparable stake: 10% 13D/G row: BIOTECHNOLOGY VALUE FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.

Comparable ownership Top 5

BIOTECHNOLOGY VALUE FUND L P 10%

MONTANOVA CAPITAL, LLC 9.7%

BlackRock, Inc. 7.8%

STATE STREET CORP 5.7%

VANGUARD CAPITAL MANAGEMENT LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	10%	$76,791,609 8,677,018 shares	+$24,465,506	30 Sep 2025
MONTANOVA CAPITAL, LLC	13D/G 13F Company 13D/G 13F	9.7%	$103,591,098 8,575,422 shares	+$12,254,218	30 Jun 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	7.8% from 13D/G	$115,286,283 10,509,233 shares	—	30 Jun 2026
STATE STREET CORP	13F 13D/G Company · STATE STREET CORPORATION 13F 13D/G	5.7% from 13D/G	$58,461,412 5,329,208 shares	—	30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC	13F 13D/G Company · Vanguard Capital Management 13F 13D/G	5% from 13D/G	$42,960,319 3,916,164 shares	—	30 Jun 2026
RA CAPITAL MANAGEMENT, L.P.	13D/G 13D/G	4.9%	$26,070,011 4,004,610 shares	$0	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

26,005

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

219

Q3 2026 holders

Holder diff

-213

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend